Disparities in LGBT Health Outcomes Improved Through Primary Care Intervention
Over a 1-year intervention period, teams of clinicians implemented culturally affirming protocols to improve their primary care practice’s ability to serve LGBT patients.
HIV/AIDS
Male Sex and Obesity Independently Associated With Residual HIV-1 Viremia Despite Suppressive ART
A cross-sectional study was performed to assess whether age, body mass index, and/or components of antiretroviral therapy contributed to persistence of HIV viremia.
Comparison of Systematic vs Test-Guided Treatment for TB in Adults With HIV
A team of investigators conducted a randomized trial comparing test-guided management of tuberculosis with systematic empirical treatment for adults with HIV infection.
Factors Contributing to Poor ART Adherence, HIV-1 Drug Resistance Explored
HIV-positive patients in the United States face significant challenges associated with poor adherence to antiretroviral therapy (ART) and HIV-1 drug resistance, according to a study published in AIDS and Behavior.
CDC: HIV Testing Occurs at <1% of Physician Visits
HIV testing occurs at less than 1% of physician office and emergency department visits and at less than 3% of community health center visits.
HIV Not Linked to Increased Risk for Severe COVID-19
Patients who are HIV-positive with a probable or proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may not be at a greater risk for severe disease or death compared with patients who are HIV-negative,
HIV Positive Men Are Not Receiving STD Testing, Prevention Services
Many sexually active men who have sex with men do not receive recommended prevention services and STD testing when receiving care for HIV infection.
Mood Disorders With HIV Increase Risk for Noncommunicable Disease
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
HIV Infection Linked to Early Menopause
Researchers studied the average age of menopause, prevalence of early menopause and premature menopause, and correlates of menopause occurring at <45 years in women living with HIV.
HIV Therapy Symtuza Approved for Use in Pediatric Patients
Symtuza is a 4-drug combination of darunavir, an HIV-1 protease inhibitor; cobicistat, a CYP3A inhibitor; and emtricitabine and tenofovir alafenamide.
-
Loading...
-
Loading...
Next post in HIV/AIDS Information Center
